Reactive arthritis is a type of arthritis that follows an infection. It may also cause inflammation of the eyes, skin and urinary and genital systems.
Reiter syndrome; Post-infectious arthritis
The exact cause of reactive arthritis is unknown. However, it most often follows an infection, but the joint itself is not infected. Reactive arthritis most often occurs in men between the ages of 20 and 40, although it does sometimes affect women. It may follow an infection in the urethra after unprotected sex. The most common bacteria that cause such infections is called Chlamydia trachomatis. Reactive arthritis can also follow a gastrointestinal infection (such as food poisoning). In up to one half of people thought to have reactive arthritis, there may be no known infection.
Certain genes may make you more likely to get this condition.
The disorder is rare in young children, but it may occur in teenagers. Reactive arthritis may occur in children ages 6 to 14 after Clostridium difficile gastrointestinal infections.
Urinary symptoms will appear within days or weeks of an infection. These symptoms may include:
A low fever along with eye discharge, burning, or redness (conjunctivitis or "pink eye") can develop over the next several weeks.
Infections in the intestine may cause diarrhea and abdominal pain. The diarrhea may be watery or bloody.
Joint pain and stiffness also begin during this time period. The arthritis may be mild or severe. Arthritis symptoms may include:
Symptoms may include skin sores on the palms and soles that look like psoriasis. There may also be small, painless ulcers in the mouth, tongue, and penis.
Your health care provider will diagnose the condition based on your symptoms. A physical exam may show signs of conjunctivitis or skin sores. Symptoms may appear at different times, so there may be a delay in making a diagnosis.
You may have the following tests:
The goal of treatment is to relieve symptoms and treat the infection that is causing this condition.
Eye problems do not need to be treated most of the time but they should be evaluated by a specialist in eye disease (ophthalmologist). The skin sores also do not need to be treated most of the time.
Your provider will prescribe antibiotics if you have an infection. Nonsteroidal anti-inflammatory drugs (NSAIDs) and pain relievers may help with joint pain. If a joint is very swollen for a long period of time, you may have corticosteroid medicine injected into the joint.
If arthritis continues in spite of NSAIDs, sulfasalazine or methotrexate may be helpful. Finally, people who do not respond to these medicines may need anti-tumor necrosis factor (TNF) biologic agents such as etanercept (Enbrel) or adalimumab (Humira) to suppress the immune system.
Physical therapy can help ease the pain. It can also help you move better and maintain muscle strength.
Reactive arthritis may go away in a few weeks, but it can last for a few months and require medicines during that time. Symptoms may return over a period of years in up to one half of the people who have this condition.
Rarely, the condition can lead to abnormal heart rhythm or problems with the aortic heart valve.
See your provider if you develop symptoms of this condition.
Avoid infections that can bring on reactive arthritis by practicing safe sex and avoiding things that can cause food poisoning.
Babu TM, Urban MA, Augenbraun MH. Urethritis. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 107.
Hudson AP, Carter JD. Reactive arthritis. In: Firestein GS, McInnes IB, Koretzky GA, Mikuls TR, Tuhina N, O'Dell JR, eds. Firestein & Kelley's Textbook of Rheumatology. 12th ed. Philadelphia, PA: Elsevier; 2025:chap 77.
Inman RD, Rahman P. Spondyloarthritis. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 244.
Weiss PF. Reactive and postinfectious arthritis. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 198.